IBEDEBI
DEAD

Serial Number

90390261

Owner

Celgene Corporation

Attorney

Xiomara Triana

Filing Date

Dec 17, 2020

Add to watchlist:

No watchlists yet
View on USPTO

IBEDEBI Trademark

Serial Number: 90390261

IBEDEBI is a trademark filed by Celgene Corporation on December 17, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Celgene Corporation (883 trademarks)

7 Powder Horn Drive
Warren, NJ 07059

Entity Type: 03

Trademark Details

Filing Date

December 17, 2020

Registration Date

Not Registered

Published for Opposition

November 30, 2021

Goods & Services

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; monoclonal antibodies

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 8, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 8, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 10, 2024 EXRA
SOU EXTENSION 5 GRANTED
Jul 10, 2024 EX5G
SOU EXTENSION 5 FILED
Jul 10, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Jul 10, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 5, 2024 EXRA
SOU EXTENSION 4 GRANTED
Jan 3, 2024 EX4G
SOU EXTENSION 4 FILED
Jan 3, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 3, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 12, 2023 EXRA
SOU EXTENSION 3 GRANTED
Jul 10, 2023 EX3G
SOU EXTENSION 3 FILED
Jul 10, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 10, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 25, 2023 EXRA
SOU EXTENSION 2 GRANTED
Jan 23, 2023 EX2G
SOU EXTENSION 2 FILED
Jan 23, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 23, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 13, 2022 EXRA
SOU EXTENSION 1 GRANTED
Jul 11, 2022 EX1G
SOU EXTENSION 1 FILED
Jul 11, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 11, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 25, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 30, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 30, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 10, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 25, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 20, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 19, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 19, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 19, 2021 GNRN
NON-FINAL ACTION E-MAILED
Apr 19, 2021 GNRT
NON-FINAL ACTION WRITTEN
Apr 19, 2021 CNRT
ASSIGNED TO EXAMINER
Apr 12, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 27, 2021 NWOS
NEW APPLICATION ENTERED
Dec 21, 2020 NWAP